The study of Intravitreal aflibercept with treat and extend regimen for macular edema with branch retinal vein occlusion (BRVO)
Phase 4
- Conditions
- Branch retinal vein occlusion
- Registration Number
- JPRN-UMIN000023200
- Lead Sponsor
- Department of Ophthalmology, Akita University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1. History of vitrectomy or glaucoma surgery 2. Other disorders such as DME, CRVO or idiopathic macular telangiectasia 3. Poor control hypertension (systolic pressure >180mmHg, diastolic pressure >100mmHg) 4. Concomitant conditions/diseases including uncontrolled glaucoma and intraocular inflammation 5. Patients who the doctor in charge judges are ineligible for the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change of BCVA from baseline to 12M
- Secondary Outcome Measures
Name Time Method 1.Change of OCT from baseline at 12M 2.The number of injections between 12M from baseline 3.Safety